One of the prominent molecular abnormalities of HPV (-) tumors is widespread loss-of-function mutations in the tumor suppressors TP53 and CDKN2A/RB1 or chromosomal loss at 9p (CDKN2A) and 3p and 17p (TP53) (Table 2). Here, CDKN2A is linked to neoplasm.